BiotechTube
Home/Herantis Pharma/Antti Vuolanto
AV

Antti Vuolanto

Chief Executive Officer

Herantis Pharma

Therapeutic Areas

Parkinson's DiseaseNeurodegenerative Diseases

Herantis Pharma Pipeline

DrugIndicationPhase
HER-096Parkinson's DiseasePhase 1b